Pharmaceutical Giant GSK Reaches Major Settlement
British pharmaceutical company GSK has agreed to pay $2.3 billion to settle lawsuits alleging that its heart burn medication Zantac caused cancer. GSK has settled 80,000 Zantac lawsuit. Watch to know ...
MARKET REPORT: GSK shares jump as Zantac cancer claims deal reached
Zantac was pulled from shelves in 2019 amid panic that a key ingredient - ranitidine - could cause cancer, plunging GSK and ...
Pharmabiz3h
GSK to resolve 93% of US state court Zantac product liability cases for up to $2.2 billion
GSK to resolve 93% of US state court Zantac product liability cases for up to $2.2 billion: London, UK Friday, October 11, 2024, 14:00 Hrs [IST] GSK plc announced that it has reac ...
Wall Street retreats from records on unemployment, inflation news
Traders around the word awaited U.S. inflation data for September—and the implications it will have for rate cuts at the ...
newtelegraphng12h
UK Firm, GSK, To Pay $2.2bn Over Zantac Cancer Claims
ShareUK pharmaceutical giant, GSK said it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...
Business Times14h
Europe: Stocks end lower after US inflation data; French budget in focus
EUROPEAN shares closed lower on Thursday (Oct 10), with defence and industrial stocks leading losses, after data showed US inflation ticked higher, while investors waited for France to unveil its 2025 ...
Unilever finally pulls out of Russia – two and a half years after Putin’s invasion of Ukraine
UNILEVER is finally calling quits on selling ice creams to Russia, two and a half years after Putin’s invasion of Ukraine. The FTSE 100 giant has come under pressure for funding the Kremlin’s war ...
Health Care Cos Down as Pfizer Weighs -- Health Care Roundup
GSK shares rose after the British drug major agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued heartburn medicine Zantac caused cancer. Write to Rob ...
GSK's Strong Vaccine and HIV Portfolios Support Steady Growth
As one of the largest pharmaceutical and vaccine companies, GSK has used its vast resources to create the next generation of healthcare treatments. The company's innovative new product lineup and ...
European markets falter following upbeat US inflation data
The Stoxx Europe 600 Index ended the session 0.2 per cent lower, extending losses after US inflation rose more than forecast.
FTSE 100 Live 10 October: GSK shares rise on $2.2bn Zantac settlement, property firm gets £1.1bn bid
GSK’s $2.2 billion Zantac settlement today put its shares top of the FTSE 100, albeit still well short of their level before litigation started in summer 2022. The drugs group rose 5% or 77.5p to 1535 ...
Europe close: Stocks inch lower after choppy session
Thursday saw choppy trading across European stock markets with the region's main benchmark finishing lower but moving within a narrow range, as investors focused on mixed economic data from the US and ...